The global at-home testing market is expected to enjoy a valuation of US$ 7.1 billion in 2022, and further expand at a CAGR of 4.0% to reach a valuation of US$ 10.5 billion by the end of the year 2032. According to a recent study by Future Market Insights, digital monitoring system products are leading the market with a share of about 46.7% in the year 2021, within the global at-home testing market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 7.1 billion |
| Market Value 2032 | US$ 10.5 billion |
| CAGR 2022 to 2032 | 4.0% |
| Market Share of Top 5 Countries | 55.5% |
| Key Market Players | Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA., Everlywell, and LetsgetChecked. |
The at-home testing market has gained popularity recently due to the numerous new alternatives it has provided for patients. They aid in the continuous monitoring of health issues, such as blood sugar and cholesterol levels, as well as the diagnosis and treatment of new patients who test positive for specific indications.
With at-home testing kits being well accepted in the market, manufacturers have seized the opportunity to offer novel kits for the well-being of patients suffering from chronic disorders, as well as in the management of several ailments.
One of the primary reasons for the market's predicted opportunistic expansion is the flexibility it affords to the self-testing audience. The rising usage of opioids and drug abuse testing has opened up new opportunities in the pain management area.
With so many brands of at-home testing kits available in the market, the FDA has set up certain regulations, including a warning about not using pre-used test strips, on 21 June 2022. It has also set up a website enlisting all the approved home tests.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for at-home testing products was approximately 5.8% of the overall ~US$ 118.5 billion of the global in-vitro diagnostics market in 2021.
The at-home testing industry has drawn a lot of attention since it offers a highly convenient way to conduct tests from the comfort of one's own home. Market players are taking advantage of this opportunity to expand their businesses and branch out into other areas
The at-home market is predicted to grow throughout the forecast period, because of the increase in business development tactics such as collaboration and acquisition by leading industry players.
For instance, Viatris Inc along with Atomo Diagnostics Limited collaborated with the globally renounced health agency Unit Aid, in the year of April 2021, to make HIV testing kits more accessible in developing countries.
Another promising reason for the lucrative growth of the market is the increasing popularity of self-testing kits among consumers . Pregnancy self-tests and blood glucose self-testing have gained so much popularity through extensive marketing that they have now become routine and useful for consumers.
To ensure the efficacy of norms, the entire regulatory landscape in the self-testing business is continually altering. In-vitro diagnostic medical devices (IVD) regulations for self-testing kits are in effect in the United States.
Owing to the aforementioned factors, the at-home testing market is expected to grow at a CAGR of 4.0% during the forecast period from 2022 to 2032.
The market is set to present an opportunistic outlook, due to technological developments in sample collection and manufacturers' efforts to develop easy-to-use disposable test kits.
These test kits use sweat, semen, and even hair samples for giving test results, which sometimes the consumer is not comfortable giving in public. At-home testing kits have made this more accessible for consumers. People can be tested easily for fertility checks and even drug abuse.
The growth will further be propelled by the adoption of self-testing policies encouraging the use of self-diagnostic kits. Developed countries are enacting self-testing policies and developing self-testing guidelines.
According to the WHO, around 41 countries have implemented HIV self-testing policies. Many countries have similar policies in place for Hepatitis B and C.
With the implementation of such government laws, the general population is encouraged to utilize self-diagnostic kits, creating significant chances for the at-home testing market to flourish.
Principal Consultant
Despite the fact that the at-home testing market includes multiple end-uses, certain challenges are expected to impede market expansion. The price increase for at-home testing kits will be a setback for this sector. Self-testing policies and recommendations are being developed in developed countries. As a result, the high pricing of testing kits will prevent the market from expanding.
Additionally, the projected expansion of the global at-home testing market is anticipated to be hampered by the rising number of product recalls of self-testing kits by regulatory bodies like the USA FDA. There are multiple pieces of evidence of such recalls in the market.
These variables in total propose an adverse consequence on the formative development of the at-home testing market.
The USA dominates the North American region with a total market share of about 91.6 % in 2021 and is expected to continue the same through the forecast period.
This is because the USA market is highly fragmented with many new market players trying to promote their products, launch multiple innovative products, high prevalence of certain chronic and infectious diseases, and high awareness among consumers. The USA Federal government has also introduced a lot of schemes and awareness programs for the higher adoption of self-test kits and to get tested.
The rate of obese people living in the USA is also high, and high diabetic awareness has increased the adoption of continuous blood glucose monitors.
China is expected to display growth at a CAGR of 5.2% in the East Asia market over the forecast period.
The market for self-testing devices in China is increasing. Medical chemistry, immunoassay, coagulation, hematology, and microbiology are all highly sought-after fields. Another indicator of potential opportunities in China is the employment of in-house manufactured devices.
Because the country's economy is intricately linked to its healthcare system, the market is expected to grow in the future years. The Chinese government's expanding initiatives to promote the healthcare sector, which is another factor fuelling demand for self-testing kits.
The United Kingdom holds the largest market share in Europe at-home testing market in 2021 generating revenue of close to US$ 386.2 million and is expected to grow with a CAGR of 2.2% during the forecasted period.
People's regular habit of visiting clinic have been replaced with the awareness of self-test kits in the market. Self-testing kits are readily accessible at pharmacies, and obtaining them has never been simpler. Numerous healthcare organizations are entering this market since they quickly produce self-test kits.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Digital monitoring systems held a market share of around 46.7% in the global market in 2021, and the segment is expected to grow with a CAGR of 4.4% during the forecast period.
The ability of sensors to record precise data for predicted, planned, and emergency maintenance adds cost efficiencies to digital monitoring. Furthermore, they are easy to use as they have stronger compliance as all the medical data is automatically stored in the system. Hence, they have a greater preference, and the market is set to expand as a result.
Blood glucose testing has shown increased demand with a market share of 70.4% globally in 2021 and is expected to grow with a CAGR of 3.8% during the forecast period.
Blood glucose monitors are widely used for home tests as they provide a timely and dependable assessment of an individual's blood glucose concentrations in order to make appropriate food, exercise, and medication decisions. In addition, they are handy, can be used for a prolonged time, and help to keep sugar levels in check.
Blood is widely used as a sample for at-home testing kits as it evaluates the overall health, checks the function of specific organs such as the liver and kidneys, and screens for genetic diseases. The segment holds the largest market share with revenue of nearly US$ 5.1 billion in the global market and is expected to grow with a CAGR of 3.8% in the forecast period.
Drug stores hold the highest market share value of 49.6% during the year 2021 globally.
This is because most drug stores and local pharmacies have multiple options for home test kits. They are easily accessible, and consumers can select from a wide range of products. The presence of established drug store chains and supermarket chains like Walmart have even increased the adoption rate. Such chains are engaging in collaborations with at-home testing kit manufacturers to promote their products.
The market is highly fragmented and there are many companies operating and launching new products in the market. Key Players such as Abbott Diagnostics, and Quest Direct (Quest Diagnostics), are adopting expansion of their business in the untapped markets and acquisition of smaller companies to promote their products.
In order to meet consumer demand and grow their customer base, other companies are also following their footsteps to do mergers and acquisitions, partnerships and collaborations, and new product launches.
The following are examples of key development strategies used by industry players in the at-home testing market:
Similarly, recent developments related to companies manufacturing at-home testing products, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | US$ billion for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa. |
| Key Market Segments Covered | Product, Application, Sample, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global at-home testing market is estimated to be worth US$ 7.1 billion in 2022 and is set to expand 1.5X over the next ten years.
The at-home testing market is expected to reach US$ 10.5 billion by the end of 2032, with sales revenue expected to register 4.0% CAGR.
The expanding research and development of the at-home testing products, increased awareness about health and hygiene, HIV health awareness, immense advertising, and increasing number of infectious diseases, are the key trends being witnessed in this market.
The USA, Japan, China, The United Kingdom, and France are the top five countries and are expected to drive demand for the at-home testing kits market.
North America is one of the key markets for at-home testing, with the USA accounting for around 91.6% of the North American at-home testing market in the year 2021.
Demand for at-home testing in Europe is expected to register a growth of 4.1% CAGR over the next ten years.
The USA, China, and the United Kingdom are the key producers of at-home testing products.
Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA, Everlywell, and LetsgetChecked, are the key players within the market.
The Japan market held a share of about 43.8% in the East Asia at-home testing market in 2021.
Digital monitoring system is the major product segment in the global at-home testing market with a share of 46.7% in the year 2021.
1. Executive Summary | At-Home Testing Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. PESTLE Analysis
4.4. Porter’s Analysis
4.5. Regulatory Scenario
4.6. Reimbursement Scenario
4.7. Sample Collection Analysis, By Country
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Global In-Vitro Diagnostics Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Awareness about Self Testing Kits
5.2.2. Transition from Lab-based Screening to Disposable Devices
5.2.3. Easy Availability & Government Recommendations
5.2.4. Rising Per Capita Disposable Income
5.2.5. Collaborations With e-Commerce Partners
5.2.6. Increasing Adoption of Dual Capability Tests
5.2.7. Regulatory Scenario
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By Sample
6.1.4. By Distribution Channel
6.1.5. By Region
6.2. 2021 Market Scenario
7. Global Market Demand in Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2015 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis by Product
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ million) Analysis 2015 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ million) Analysis 2015 to 2021
9.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) Analysis by Product, 2015 to 2021
10.3. Current and Future Market Size (US$ million) Analysis and Forecast by Product, 2022 to 2032
10.3.1. Digital Monitoring Instruments
10.3.2. Cassettes
10.3.3. Midstreams
10.3.4. Strips
10.3.5. Cups
10.3.6. Dip Cards
10.3.7. Test Panels
10.3.8. Sample collection kits
10.3.9. Others
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Application, 2015 to 2021
11.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Application, 2022 to 2032
11.3.1. Blood Glucose Testing
11.3.2. Pregnancy & Fertility Testing
11.3.3. Cancer Testing
11.3.4. Search and Rescue
11.3.5. STD/ STI Testing
11.3.5.1. Chlamydia and Gonorrhea
11.3.5.2. HIV Testing
11.3.6. Cholesterol Testing
11.3.7. Testosterone
11.3.8. Drug of Abuse Testing
11.3.9. Cholesterol Testing
11.3.10. Thyroid Testing
11.3.11. Others
11.4. Market Attractiveness Analysis by Application
12. Global Market Analysis, By Sample
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ million) Analysis by Sample, 2015 to 2021
12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Sample, 2022 to 2032
12.3.1. Urine
12.3.2. Blood
12.3.3. Saliva
12.3.4. Stool
12.3.5. Vaginal Swab
12.3.6. Semen
12.4. Market Attractiveness Analysis by Sample
13. Global Market Analysis, By Distribution Channel
13.1. Introduction
13.2. Historical Market Size (US$ million) Analysis by Distribution Channel, 2015 to 2021
13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Distribution Channel, 2022 to 2032
13.3.1. Drug Stores
13.3.2. Hospital Pharmacies
13.3.3. Online Channels
13.4. Market Attractiveness Analysis by Distribution Channel
14. Global Market Analysis, by Region
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Region, 2015 to 2021
14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. South Asia
14.3.5. East Asia
14.3.6. Oceania
14.3.7. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. North America Market Analysis
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. The USA
15.3.1.2. Canada
15.3.2. By Product
15.3.3. By Application
15.3.4. By Sample
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By Sample
15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. The USA Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By Sample
15.8.1.2.4. By Distribution Channel
15.8.2. Canada Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By Sample
15.8.2.2.4. By Distribution Channel
16. Latin America Market Analysis
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Application
16.3.4. By Sample
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Application
16.4.3. By Sample
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Brazil Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By Sample
16.8.1.2.4. By Distribution Channel
16.8.2. Mexico Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By Sample
16.8.2.2.4. By Distribution Channel
16.8.3. Argentina Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By Sample
16.8.3.2.4. By Distribution Channel
17. Europe Market Analysis
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. The United Kingdom
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Product
17.3.3. By Application
17.3.4. By Sample
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Application
17.4.3. By Sample
17.4.4. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Germany Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By Sample
17.8.1.2.4. By Distribution Channel
17.8.2. Italy Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By Sample
17.8.2.2.4. By Distribution Channel
17.8.3. France Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By Sample
17.8.3.2.4. By Distribution Channel
17.8.4. The United Kingdom Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Application
17.8.4.2.3. By Sample
17.8.4.2.4. By Distribution Channel
17.8.5. Spain Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Application
17.8.5.2.3. By Sample
17.8.5.2.4. By Distribution Channel
17.8.6. BENELUX Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Application
17.8.6.2.3. By Sample
17.8.6.2.4. By Distribution Channel
17.8.7. Russia Market Analysis
17.8.7.1. Introduction
17.8.7.2. Market Analysis and Forecast by Market Taxonomy
17.8.7.2.1. By Product
17.8.7.2.2. By Application
17.8.7.2.3. By Sample
17.8.7.2.4. By Distribution Channel
18. South Asia Market Analysis
18.1. Introduction
18.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Vietnam
18.3.1.6. Philippines
18.3.1.7. Rest of South Asia
18.3.2. By Product
18.3.3. By Application
18.3.4. By Sample
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By Sample
18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By Sample
18.8.1.2.4. By Distribution Channel
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By Sample
18.8.2.2.4. By Distribution Channel
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By Sample
18.8.3.2.4. By Distribution Channel
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By Sample
18.8.4.2.4. By Distribution Channel
18.8.5. Vietnam Market Analysis
18.8.5.1. Introduction
18.8.5.2. Market Analysis and Forecast by Market Taxonomy
18.8.5.2.1. By Product
18.8.5.2.2. By Application
18.8.5.2.3. By Sample
18.8.5.2.4. By Distribution Channel
18.8.6. Philippines Market Analysis
18.8.6.1. Introduction
18.8.6.2. Market Analysis and Forecast by Market Taxonomy
18.8.6.2.1. By Product
18.8.6.2.2. By Application
18.8.6.2.3. By Sample
18.8.6.2.4. By Distribution Channel
19. East Asia Market Analysis
19.1. Introduction
19.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By Application
19.3.4. By Sample
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Application
19.4.3. By Sample
19.4.4. By Distribution Channel
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. China Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By Sample
19.8.1.2.4. By Distribution Channel
19.8.2. Japan Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By Sample
19.8.2.2.4. By Distribution Channel
19.8.3. South Korea Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Application
19.8.3.2.3. By Sample
19.8.3.2.4. By Distribution Channel
20. Oceania Market Analysis
20.1. Introduction
20.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
20.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Application
20.3.4. By Sample
20.3.5. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Application
20.4.3. By Sample
20.4.4. By Distribution Channel
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country-Level Analysis & Forecast
20.8.1. Australia Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application
20.8.1.2.3. By Sample
20.8.1.2.4. By Distribution Channel
20.8.2. New Zealand Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application
20.8.2.2.3. By Sample
20.8.2.2.4. By Distribution Channel
21. Middle East and Africa Market Analysis
21.1. Introduction
21.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
21.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. North Africa
21.3.1.4. South Africa
21.3.1.5. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Application
21.3.4. By Sample
21.3.5. By Distribution Channel
21.4. Market Attractiveness Analysis
21.4.1. By Product
21.4.2. By Application
21.4.3. By Sample
21.4.4. By Distribution Channel
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
21.8. Country-Level Analysis & Forecast
21.8.1. GCC Countries Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By Application
21.8.1.2.3. By Sample
21.8.1.2.4. By Distribution Channel
21.8.2. Turkey Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By Application
21.8.2.2.3. By Sample
21.8.2.2.4. By Distribution Channel
21.8.3. North Africa Market Analysis
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast by Market Taxonomy
21.8.3.2.1. By Product
21.8.3.2.2. By Application
21.8.3.2.3. By Sample
21.8.3.2.4. By Distribution Channel
21.8.4. South Africa Market Analysis
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast by Market Taxonomy
21.8.4.2.1. By Product
21.8.4.2.2. By Application
21.8.4.2.3. By Sample
21.8.4.2.4. By Distribution Channel
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
22.3.1. Regional Footprint by Players
22.3.2. Product Footprint by Players
22.3.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Abbott
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Sales Footprint
23.3.1.4. Key Financials
23.3.1.5. SWOT Analysis
23.3.1.6. Strategy Overview
23.3.1.6.1. Marketing Strategy
23.3.1.6.2. Product strategy
23.3.1.6.3. Channel Strategy
23.3.2. Becton, Dickinson and Company.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Sales Footprint
23.3.2.4. Key Financials
23.3.2.5. SWOT Analysis
23.3.2.6. Strategy Overview
23.3.2.6.1. Marketing Strategy
23.3.2.6.2. Product strategy
23.3.2.6.3. Channel Strategy
23.3.3. ACCESS BIO
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Sales Footprint
23.3.3.4. Key Financials
23.3.3.5. SWOT Analysis
23.3.3.6. Strategy Overview
23.3.3.6.1. Marketing Strategy
23.3.3.6.2. Product strategy
23.3.3.6.3. Channel Strategy
23.3.4. CELLTRION INC.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Sales Footprint
23.3.4.4. Key Financials
23.3.4.5. SWOT Analysis
23.3.4.6. Strategy Overview
23.3.4.6.1. Marketing Strategy
23.3.4.6.2. Product strategy
23.3.4.6.3. Channel Strategy
23.3.5. Siemens Healthcare GmbH
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Sales Footprint
23.3.5.4. Key Financials
23.3.5.5. SWOT Analysis
23.3.5.6. Strategy Overview
23.3.5.6.1. Marketing Strategy
23.3.5.6.2. Product strategy
23.3.5.6.3. Channel Strategy
23.3.6. ACON Laboratories Inc.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Sales Footprint
23.3.6.4. Key Financials
23.3.6.5. SWOT Analysis
23.3.6.6. Strategy Overview
23.3.6.6.1. Marketing Strategy
23.3.6.6.2. Product Strategy
23.3.6.6.3. Channel Strategy
23.3.7. ARKRAY, Inc
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Sales Footprint
23.3.7.4. Key Financials
23.3.7.5. SWOT Analysis
23.3.7.6. Strategy Overview
23.3.7.6.1. Marketing Strategy
23.3.7.6.2. Product Strategy
23.3.7.6.3. Channel Strategy
23.3.8. F. Hoffmann-La Roche Ltd.
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Sales Footprint
23.3.8.4. Key Financials
23.3.8.5. SWOT Analysis
23.3.8.6. Strategy Overview
23.3.8.6.1. Marketing Strategy
23.3.8.6.2. Product strategy
23.3.8.6.3. Channel Strategy
23.3.9. OraSure, Technologies Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Sales Footprint
23.3.9.4. Key Financials
23.3.9.5. SWOT Analysis
23.3.9.6. Strategy Overview
23.3.9.6.1. Marketing Strategy
23.3.9.6.2. Product strategy
23.3.9.6.3. Channel Strategy
23.3.10. Quest Diagnostics
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Sales Footprint
23.3.10.4. Key Financials
23.3.10.5. SWOT Analysis
23.3.10.6. Strategy Overview
23.3.10.6.1. Marketing Strategy
23.3.10.6.2. Product strategy
23.3.10.6.3. Channel Strategy
23.3.11. Bionime Corporation
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Sales Footprint
23.3.11.4. Key Financials
23.3.11.5. SWOT Analysis
23.3.11.6. Strategy Overview
23.3.11.6.1. Marketing Strategy
23.3.11.6.2. Product strategy
23.3.11.6.3. Channel Strategy
23.3.12. Btnx Inc.
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Sales Footprint
23.3.12.4. Key Financials
23.3.12.5. SWOT Analysis
23.3.12.6. Strategy Overview
23.3.12.6.1. Marketing Strategy
23.3.12.6.2. Product strategy
23.3.12.6.3. Channel Strategy
23.3.13. iHealth Labs Inc.
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Sales Footprint
23.3.13.4. Key Financials
23.3.13.5. SWOT Analysis
23.3.13.6. Strategy Overview
23.3.13.6.1. Marketing Strategy
23.3.13.6.2. Product strategy
23.3.13.6.3. Channel Strategy
23.3.14. InBios International, Inc. USA.
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Sales Footprint
23.3.14.4. Key Financials
23.3.14.5. SWOT Analysis
23.3.14.6. Strategy Overview
23.3.14.6.1. Marketing Strategy
23.3.14.6.2. Product strategy
23.3.14.6.3. Channel Strategy
23.3.15. Everlywell
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Sales Footprint
23.3.15.4. Key Financials
23.3.15.5. SWOT Analysis
23.3.15.6. Strategy Overview
23.3.15.6.1. Marketing Strategy
23.3.15.6.2. Product strategy
23.3.15.6.3. Channel Strategy
23.3.16. LetsgetChecked
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Sales Footprint
23.3.16.4. Key Financials
23.3.16.5. SWOT Analysis
23.3.16.6. Strategy Overview
23.3.16.6.1. Marketing Strategy
23.3.16.6.2. Product strategy
23.3.16.6.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Healthcare
June 2023
REP-GB-6108
342 pages
Explore Healthcare Insights
View Reports
At-Home Testing Market
